These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14998429)

  • 1. The effect of hypertension and hypercholesterolemia screening with subsequent intervention letter on the use of blood pressure and lipid lowering drugs.
    Atthobari J; Monster TB; de Jong PE; de Jong-van den Berg LT;
    Br J Clin Pharmacol; 2004 Mar; 57(3):328-36. PubMed ID: 14998429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National trends in screening, prevalence, and treatment of cardiovascular risk factors.
    Natarajan S; Nietert PJ
    Prev Med; 2003 Apr; 36(4):389-97. PubMed ID: 12649046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whom are we treating with lipid-lowering drugs? Are we following the guidelines? Evidence from a population-based study: the Tromso study 2001.
    Hartz I; Eggen AE; Grimsgaard S; Skjold F; Njølstad I
    Eur J Clin Pharmacol; 2004 Nov; 60(9):643-9. PubMed ID: 15455181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and outcomes of screening for cardiovascular risk factors in the emergency department.
    Tan N; Taylor DM
    Emerg Med Australas; 2013 Apr; 25(2):175-81. PubMed ID: 23560969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypertension and hypercholesterolemia in the Czech population].
    Wohlfahrt P; Krajčoviechová A; Bruthans J; Cífková R
    Vnitr Lek; 2016; 62(11):863-867. PubMed ID: 28128571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription of Lipid-Lowering and Antihypertensive Drugs Following Pictorial Information About Subclinical Atherosclerosis: A Secondary Outcome of a Randomized Clinical Trial.
    Sjölander M; Carlberg B; Norberg M; Näslund U; Ng N
    JAMA Netw Open; 2021 Aug; 4(8):e2121683. PubMed ID: 34410393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of antihypertensive and lipid-lowering drugs: the management of cardiovascular risk in clinical practice.
    Di Martino M; Degli Esposti L; Filigheddu F; Veronesi C; Salerno G; Saragoni S; Glorioso N; Didoni G; Degli Esposti E
    J Hum Hypertens; 2007 Jan; 21(1):53-9. PubMed ID: 17036042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between hypercholesterolemia and hypertension: implications for therapy.
    Borghi C
    Curr Opin Nephrol Hypertens; 2002 Sep; 11(5):489-96. PubMed ID: 12187312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological management of modifiable cardiovascular risk factors (blood pressure and lipids) following diagnosis of myocardial infarction, stroke and diabetes: comparison between population-based studies in Russia and Norway.
    Cook S; Hopstock LA; Eggen AE; Bates K; Iakunchykova O; Kontsevaya A; McKee M; Schirmer H; Voevoda M; Kudryavtsev AV; Malyutina S; Leon DA
    BMC Cardiovasc Disord; 2020 May; 20(1):234. PubMed ID: 32430002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Under-use of appropriate blood pressure-lowering and lipid-lowering therapy in the Busselton baby boomer population.
    Yiu W; Knuiman M; Wallace H; Hung J
    Aust J Gen Pract; 2019 Dec; 48(12):883-889. PubMed ID: 31774993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP.
    Wens J; Gerard R; Vandenberghe H
    Prim Care Diabetes; 2011 Apr; 5(1):19-24. PubMed ID: 21030327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
    Lan J; Zhao Y; Dong F; Yan Z; Zheng W; Fan J; Sun G
    J Ethnopharmacol; 2015 Feb; 161():69-81. PubMed ID: 25498346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial.
    Gupta A; Mackay J; Whitehouse A; Godec T; Collier T; Pocock S; Poulter N; Sever P
    Lancet; 2018 Sep; 392(10153):1127-1137. PubMed ID: 30158072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment of hypertension and hyperlipidemia in Izhevsk, Russia.
    Cybulsky M; Cook S; Kontsevaya AV; Vasiljev M; Leon DA
    BMC Cardiovasc Disord; 2016 Jun; 16():122. PubMed ID: 27255373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of hypercholesterolemia in the hypertensive patient.
    Cressman MD
    Cleve Clin J Med; 1989 Jun; 56(4):351-8. PubMed ID: 2663224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood Pressure and Cholesterol-lowering Efficacy of a Fixed-dose Combination With Irbesartan and Atorvastatin in Patients With Hypertension and Hypercholesterolemia: A Randomized, Double-blind, Factorial, Multicenter Phase III Study.
    Kim SH; Jo SH; Lee SC; Lee SY; Yoon MH; Lee HL; Lee NH; Ha JW; Lee NH; Kim DW; Han GR; Hyon MS; Cho DG; Park CG; Kim YD; Ryu GH; Kim CH; Kim KS; Chung MH; Chae SC; Seung KB; Oh BH
    Clin Ther; 2016 Oct; 38(10):2171-2184. PubMed ID: 27742464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study.
    Borghi C; Dormi A; Veronesi M; Sangiorgi Z; Gaddi A;
    Am Heart J; 2004 Aug; 148(2):285-92. PubMed ID: 15308998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study in primary care in patients without vascular disease comparing levels of coronary risk factors in those recommended for lipid-lowering drugs based on either absolute risk or absolute risk reduction.
    Ramachandran S; Croft P; Neary RH
    Prev Cardiol; 2003; 6(1):17-21. PubMed ID: 12624557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription patterns of lipid lowering agents among older patients in general practice: an analysis from a national database in the Netherlands.
    Kleipool EEF; Nielen MMJ; Korevaar JC; Harskamp RE; Smulders YM; Serné E; Thijs A; Peters MJL; Muller M
    Age Ageing; 2019 Jul; 48(4):577-582. PubMed ID: 31074492
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.